BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
Loading
Interest Income Over TimeContracting
Percentile Rank86
3Y CAGR+27.7%
5Y CAGR+2.5%
Year-over-Year Change
Income earned from interest-bearing assets
3Y CAGR
+27.7%/yr
vs +22.8%/yr prior
5Y CAGR
+2.5%/yr
Recent acceleration
Acceleration
+4.8pp
Accelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $10.67M | -27.7% |
| 2024 | $14.75M | -6.5% |
| 2023 | $15.78M | +207.7% |
| 2022 | $5.13M | +8169.4% |
| 2021 | $62000.00 | -99.3% |
| 2020 | $9.42M | +387.3% |
| 2019 | $1.93M | -14.2% |
| 2018 | $2.25M | +121.9% |
| 2017 | $1.01M | +28.0% |
| 2016 | $793000.00 | - |